Enhancing Exposure Therapy for Post-traumatic Stress Disorder

Stopped early · Phase 2

Conditions studied: Chronic Posttraumatic Stress Disorder

In brief

This study is investigating a new brief psychotherapy for post-traumatic stress disorder (PTSD) which, modifies an already proven psychotherapy for PTSD by adding two new components and modifying several others. The goal of the study is to determine whether this experimental treatment outperforms the well-established standard treatment.

Key facts

Study ID: NCT01574118
Run by: University of Texas at Austin
People needed: 27
Starts: 2012-04-01
Expected to finish: 2020-03-01
Last updated by the study team: 2022-08-29

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

Current primary PTSD diagnosis based on DSM-IV criteria, with a minimum duration of 12 weeks since the traumatic event.
Between the age of 18 and 65.
Medication status stable for at least 6 weeks

You may not qualify if…

Current diagnosis of schizophrenia, delusional disorder, or organic mental disorder as defined by the DSM-IV.
Current diagnosis of bipolar disorder, depression with psychotic features, or depression severe enough to require immediate psychiatric treatment (i.e., serious suicide risk with intent and plan).
Current diagnosis of alcohol or substance dependence within the 3 previous months.
Unwilling or unable to discontinue current trauma-focused psychotherapy.
Ongoing intimate relationship with the perpetrator (in assault-related PTSD cases).
Other severe acute or chronic medical or psychiatric condition that, in the judgment of the Medical Director, would make the participant inappropriate for entry.

Where it is running

Laboratory for the Study of Anxiety Disorders, University of Texas at Austin — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.